Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis.

Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis. J Thromb Haemost. 2018 01; 16(1):39-43.

View in: PubMed

subject areas

Antibodies, Neutralizing
Child, Preschool
Coagulants
Factor VIII
Hemophilia A
Humans
Male
Randomized Controlled Trials as Topic
Recombinant Proteins
Time Factors
Treatment Outcome

authors with profiles

Mindy Simpson